SNP genotyping of a sclerosing rhabdomyosarcoma: reveals highly aneuploid profile and a specific MDM2/HMGA2 amplification

Human Pathology

Volumn 40, Issue 9, 2009, Pages 1347-1352

  Bouron Dal Soglio, Dorothée ^a,b   Rougemont, Anne Laure ^a,b   Absi, Riwa ^a,b   Barrette, Stéphane ^a   Montpetit, Alexandre ^c   Fetni, Raouf ^a,b   Fournet, Jean Christophe ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Centre d'Innovation   (Canada)

Author keywords

HMGA2; MDM2; Sclerosing rhabdomyosarcoma; SNP array genotyping

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; PROTEIN MDM2;

ANEUPLOIDY; ARTICLE; CASE REPORT; CHILD; CHROMOSOME 12Q; GENE AMPLIFICATION; GENE IDENTIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; RHABDOMYOSARCOMA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR DIFFERENTIATION;

ANEUPLOIDY; CHILD; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; RHABDOMYOSARCOMA;

EID: 68549109508     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.021     Document Type: Article

References (15)

1. Parham D.M., and Ellison D.A. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130 (2006) 1454-1465
2. Chiles M.C., Parham D.M., Qualman S.J., et al. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol 7 (2004) 583-594
3. Croes R., Debiec-Rychter M., Cokelaere K., De Vos R., Hagemeijer A., and Sciot R. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma. Virchows Arch 446 (2005) 64-67
4. Mentzel T., and Katenkamp D. Sclerosing, pseudovascular rhabdomyosarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases. Virchows Arch 436 (2000) 305-311
5. Folpe A.L., McKenney J.K., Bridge J.A., and Weiss S.W. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26 (2002) 1175-1183
6. Vadgama B., Sebire N.J., Malone M., and Ramsay A.D. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature. Pediatr Dev Pathol 7 (2004) 391-396
7. Zambrano E., Perez-Atayde A.R., Ahrens W., and Reyes-Mugica M. Pediatric sclerosing rhabdomyosarcoma. Int J Surg Pathol 14 (2006) 193-199
8. Peiffer D.A., Le J.M., Steemers F.J., et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16 (2006) 1136-1148
9. Kuhnen C., Herter P., Leuschner I., et al. Sclerosing pseudovascular rhabdomyosarcoma-immunohistochemical, ultrastructural, and genetic findings indicating a distinct subtype of rhabdomyosarcoma. Virchows Arch 449 (2006) 572-578
10. Ragazzini P., Gamberi G., Pazzaglia L., et al. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol 19 (2004) 401-411
11. Goldstein M., Meller I., Issakov J., and Orr-Urtreger A. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors. Neoplasia 8 (2006) 332-343
12. Bridge J.A., Liu J., Qualman S.J., et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33 (2002) 310-321
13. Italiano A., Bianchini L., Keslair F., et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer (2008)
14. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., and Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362 (1993) 857-860
15. Cocker H.A., Hobbs S.M., Tiffin N., Pritchard-Jones K., Pinkerton C.R., and Kelland L.R. High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance. Br J Cancer 85 (2001) 1746-1752